Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cynata Therapeutics Ord Shs V.CYP


Primary Symbol: CYYNF

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.


OTCPK:CYYNF - Post by User

Post by johnu48on Jul 08, 2020 4:05pm
204 Views
Post# 31241505

RE: Going forward step by step

RE: Going forward step by stepAmazing, LI up 30% or 30 cents today and CYP can't manage to go up a penny.  Anyone think someone is holding the SP of CYP down .  Sure looks like to me. 700,000 Shares and remains Status Quo, something don't jive.  CYP is in the same neighbourhood, PFS released, farther along in development and a better property.  What's in a name,probably a whole lot to the genreal buying public.  Ca't make the connection to Lithium.  Mgmt isn't helping either with the lack of promotion at a time when they  should be piggy backing on Li success.  Where'e Mosher, Willoughby and the rest of the gang. These price surges don't last for ever.  Cyp may be missing the boat.
<< Previous
Bullboard Posts
Next >>